首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
ADR updates from Canada
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
1997年
/ 635卷
/ 1期
关键词
:
Pulmonary Hypertension;
Nifedipine;
Fluconazole;
Fenfluramine;
Primary Pulmonary Hypertension;
D O I
:
10.2165/00128415-199706350-00006
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:3 / 3
相关论文
共 50 条
[41]
Recent Product Monograph updates in Canada
Reactions Weekly,
2018,
1719
(1)
: 1
-
1
[42]
Accreditation Canada includes ADR reporting in new standards
Reactions Weekly,
2013,
1438
(1)
: 4
-
4
[43]
Health Canada updates protozoa, turbidity standards
不详
论文数:
0
引用数:
0
h-index:
0
不详
JOURNAL AMERICAN WATER WORKS ASSOCIATION,
2005,
97
(08):
: 26
-
27
[44]
Health Canada updates ceftriaxone prescribing information
Reactions Weekly,
2009,
1275
(1)
: 3
-
3
[45]
Health Canada updates information about Tamiflu
Reactions Weekly,
2006,
1131
(1)
: 2
-
2
[46]
Six CPM updates featured by Health Canada
Reactions Weekly,
2018,
1706
(1)
: 7
-
7
[47]
Recent CPM updates highlighted by Health Canada
Reactions Weekly,
2019,
1740
(1)
: 4
-
4
[48]
Six CPM Updates Featured By Health Canada
不详
论文数:
0
引用数:
0
h-index:
0
不详
PHARMACEUTICAL MEDICINE,
2018,
32
(04)
: 303
-
303
[49]
Tequin: labelling updates in US, warnings in Canada
Reactions Weekly,
2006,
1090
(1)
: 3
-
3
[50]
Health Canada has received 189 ADR reports suspected to be associated with atomoxetine use, according to Heather Morrison from Health Canada.
Reactions Weekly,
2008,
1211
(1)
: 3
-
3
←
1
2
3
4
5
→